have been devoted to controlling peptoid amide bond
geometry in order to minimize backbone conformational
heterogeneity. For example, it was demonstrated that
chain exhibits a Kcis/trans value of 6.3 in acetonitrile,7b
as determined from the same monomeric model, and
triazolium-type side chains have Kcis/trans values around 11.9
n f π*Ar donation from the oxygen of a carbonyl (Oiꢀ1
)
to the antibonding orbital (π*) of the aromatic ring of
an R-branched benzylic-type side chain (residue iþ1)
stabilizes the cis-amide conformation.7,8 The triazolium-
containing side chain is a prominent example of a side
chain which utilizes the n f π*Ar effect to enforce the cis-
geometry, independently of any steric contributions.9 The
1-naphthylethyl side chain (1npe) has also been proposed
in this context and has allowed for the first homogeneous
and robust PPI-type peptoid helices to be prepared.5 From
X-ray analysis of the shorter Ns1npe oligomers it was
however concluded that steric interactions are certainly
the primary cause for conformational restriction in this
family. The role of side chain steric hindrance in promoting
cis amides is actually well-known.7b So, for example,
N-CR-branched side chains are commonly used for pro-
moting PPI-type helices. However, with the exception of
the 1npe side chain, no other sterically hindered side chain
capable of ensuring complete control of R-peptoid amide
geometry has beendescribed todate. The highly bulky tert-
butyl side chain has been shown to produce exclusively
the cis amide conformation in N-substituted aminomethyl
benzamides, termed arylopeptoids,10 but insertion of tert-
butyl groups in R-peptoids had never been reported.11 In
this communication we demonstrate the full cis-directing
effect of the tBu side chain in R-peptoids and also report its
use for the design and construction of peptoids displaying
alternated cis and trans amides in a controlled manner.
The effect of a tBu side chain on cis/trans amide
isomerism was first studied in the monomeric model 1
capped with acetyl and piperidinyl groups (Scheme 1).12
Whatever the solvent used for NMR analysis including
deuterated water, only one rotamer was observed
(Kcis/trans > 19), whose cis geometry was firmly established
by 2D-NOESY experiments. The tBu effect on the back-
bone amide is remarkable. By comparison, the 1npe side
Scheme 1. Preparation of Model 1 and Cis/Trans Ratios
(Kcis/trans) Determined by NMR in Various Solvents (CDCl3,
CD3CN, (CD3)2CO, MeOD, D2O)
Next, we turned our attention to the solution-phase
synthesis of NtBu homo-oligomers by the submonomer
method. The initial conditions for the acylationꢀsubstitu-
tion iterations from N-tert-butyl glycine 3 were as follows:
bromoacetyl bromide in THF/Et3N at 0 °C for the first
step followed by the reaction of bromoacetamide inter-
mediates with tBuNH2 (4 equiv) in THF/Et3N at rt. These
conditions furnished only modest yields in bromoaceta-
mides, around 60%. We then found that replacing bro-
moacetyl bromide by freshly prepared bromoacetic
anhydride produced better yields.13 With the optimized
conditions (Scheme 2), chromatography is needed only
once by iteration, after the acylation; the excess of tBuNH2
used in the substitution is just evaporated off.14 The crude
secondary amines were directly used in the next iteration or
capped with an acetyl group to yield compounds 4ꢀ7.
Although tedious it might be possible to synthesize longer
NtBu glycine oligomers in solution, following our bro-
moacetic anhydride based protocol. A block approach
consisting of coupling short oligomers would, however,
be more straightforward to access longer oligomers. With
this in mind several conditions were tested for coupling
the amine 3 and the monomer acid AcꢀNtBuꢀOH. What-
ever the conditions used (HATU/DIEA, PyBrOP/DIEA,
EDCI/DMAP, and DIC/DMAP), the expected dimer 4
was not observed or produced in a very poor yield, not
exceeding 10%. Accordingly, the very sterically demand-
ing tBu side chain prevents any peptide coupling reaction,
even in solution.
(6) (a) Gorske, B. C.; Blackwell, H. E. J. Am. Chem. Soc. 2006, 128,
14378. (b) Huang, K.; Wu, C. W.; Sanborn, T. J.; Patch, J. A.;
Kirshenbaum, K.; Zuckermann, R. N.; Barron, A. E.; Radhakrishnan,
I. J. Am. Chem. Soc. 2006, 128, 1733. (c) Fowler, S. A.; Luechapanichkul,
R.; Blackwell, H. E. J. Org. Chem. 2009, 74, 1440.
(7) (a) Gorske, B. C.; Bastian, B. L.; Geske, G. D.; Blackwell, H. E.
J. Am. Chem. Soc. 2007, 129, 8928. (b) Gorske, B. C.; Stringer, J. R.;
Bastian, B. L.; Fowler, S. A.; Blackwell, H. E. J. Am. Chem. Soc. 2009,
131, 16555.
(8) The effect of thioamides in peptoids has been addressed recently:
Laursen, J. S.; Engel-Andreasen, J.; Fristrup, P.; Harris, P.; Olsen, C. A.
J. Am. Chem. Soc. 2013, 135, 2835.
(9) Caumes, C.; Roy, O.; Faure, S.; Taillefumier, C. J. Am. Chem.
Soc. 2012, 134, 9553.
1H and 13C NMR analysis of the NtBu series in various
deuterated solvents showed that these peptoids display
conformational homogeneity in solution. For example,
dimer 4 displays a unique set of resonances in CDCl3,
C6D6, CD3CN, CD3OD, (CD3)2CO, and(CD3)2SO, (see SI
(10) (a) Hjelmgaard, T.; Faure, S.; Staerk, D.; Taillefumier, C.;
Nielsen, J. Eur. J. Org. Chem. 2011, 4121. (b) Hjelmgaard, T.; Faure,
S.; De Santis, E.; Staerk, D.; Alexander, B. D.; Edwards, A. A.;
Taillefumier, C.; Nielsen, J. Tetrahedron 2012, 68, 4444.
(13) Bromoacetic anhydride is scarcely used in peptoid synthesis; see:
(a) Saha, U. K.; Roy, R. J. Chem. Soc., Chem. Commun. 1995, 2571.
(b) Hara, T.; Durell, S. R.; Myers, M. C.; Appella, D. H. J. Am. Chem.
Soc. 2006, 128, 1995. (c) Mas-Moruno, C.; Cruz, L. J.; Mora, P.;
Francesch, A.; Messeguer, A.; Perez-Paya, E.; Albericio, F. J. Med.
Chem. 2007, 50, 2443. (d) Jagasia, R.; Holub, J. M.; Bollinger, M.;
Kirshenbaum, K.; Finn, M. G. J. Org. Chem. 2009, 74, 2964.
(14) Our group has developed a highly convenient solution-phase
methodology using volatile amines: Caumes, C.; Hjelmgaard, T.;
Remuson, R.; Faure, S.; Taillefumier, C. Synthesis 2011, 257.
(11) It has been shown in peptides that the cis-isomer population of
the prolyl amide bond is enhanced when a proline residue is replaced by a
sterically hindered 5-tert-butylproline residue: (a) Halab, L.; Lubell,
W. D. J. Am. Chem. Soc. 2002, 124, 2474. (b) Halab, L.; Becker, J. A. J.;
ꢀ
ꢀ
ꢀ
Darula, Z.; Tourwe, D.; Kieffer, B. L.; Simonin, F.; Lubell, W. D.
J. Med. Chem. 2002, 45, 5353.
(12) This model is well suited for predicting the cis/trans ratio
(Kcis/trans) in oligomers: see ref 7b.
B
Org. Lett., Vol. XX, No. XX, XXXX